| scholarly article | Q13442814 |
| P50 | author | Ali Bazarbachi | Q57964105 |
| Oliver Hohn | Q59661996 | ||
| Hiba El Hajj | Q93272030 | ||
| Claudia Kücherer | Q47006514 | ||
| Ulrich Marcus | Q47161419 | ||
| P2093 | author name string | Norbert Bannert | |
| Stephen Norley | |||
| Ruth Zimmermann | |||
| P2860 | cites work | HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates. | Q55239458 |
| The seroepidemiology of human T-lymphotropic viruses: types I and II in Europe: a prospective study of pregnant women. | Q55239522 | ||
| Emergence of unique primate T-lymphotropic viruses among central African bushmeat hunters | Q24529110 | ||
| Discovery of a new human T-cell lymphotropic virus (HTLV-3) in Central Africa | Q24810230 | ||
| HTLV-3/STLV-3 and HTLV-4 viruses: discovery, epidemiology, serology and molecular aspects | Q27015081 | ||
| Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma | Q29615115 | ||
| HTLV-3/4 and simian foamy retroviruses in humans: discovery, epidemiology, cross-species transmission and molecular virology | Q30424469 | ||
| The origin and evolution of human T-cell lymphotropic virus type II (HTLV-II) and the relationship with its replication strategy | Q33678682 | ||
| Genomic evolution, patterns of global dissemination, and interspecies transmission of human and simian T-cell leukemia/lymphotropic viruses. | Q33684383 | ||
| Increased all-cause and cancer mortality in HTLV-II infection. | Q33936349 | ||
| A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia | Q34274580 | ||
| The epidemiology and disease outcomes of human T-lymphotropic virus type II. | Q34375809 | ||
| A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven sampling | Q34584310 | ||
| Establishment of the milk-borne transmission as a key factor for the peculiar endemicity of human T-lymphotropic virus type 1 (HTLV-1): the ATL Prevention Program Nagasaki | Q35145083 | ||
| Human T-lymphotropic virus type II and neurological disease. | Q35827423 | ||
| Respiratory and urinary tract infections, arthritis, and asthma associated with HTLV-I and HTLV-II infection | Q35879289 | ||
| High variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14). | Q36123087 | ||
| Epidemiological Aspects and World Distribution of HTLV-1 Infection | Q36400825 | ||
| Seroepidemiology of HTLV-I in relation to that of HIV-1 in the Gauteng region, South Africa, using dried blood spots on filter papers | Q36504681 | ||
| Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification | Q36689718 | ||
| Use of dried blood spots for the detection and confirmation of HTLV-I specific antibodies for epidemiological purposes. | Q37268551 | ||
| Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study | Q37335623 | ||
| Neurologic abnormalities in HTLV-I- and HTLV-II-infected individuals without overt myelopathy. | Q37337046 | ||
| Inflammatory manifestations of HTLV-1 and their therapeutic options | Q38262169 | ||
| The risk of development of HTLV-I-associated myelopathy/tropical spastic paraparesis among persons infected with HTLV-I. | Q39120378 | ||
| Human T lymphotropic virus type II (HTLV-II): epidemiology, molecular properties, and clinical features of infection | Q39429637 | ||
| Dried blood spots are an acceptable and useful HIV surveillance tool in a remote developing world setting | Q39477314 | ||
| HTLV-1 uveitis (HU) | Q39580544 | ||
| Prevalence and molecular characterization of human T cell leukemia virus type 2 in a group of intravenous drug users coinfected with HIV type 1 in Portugal | Q39719715 | ||
| Human T-lymphotropic virus types 1 and 2 are rare among intravenous drug users in Eastern Europe | Q39737206 | ||
| Zoonotic Transmission of Two New Strains of Human T-lymphotropic Virus Type 4 in Hunters Bitten by a Gorilla in Central Africa | Q40690106 | ||
| Dried blood spot testing for the antenatal screening of HTLV, HIV, syphilis, toxoplasmosis and hepatitis B and C: prevalence, accuracy and operational aspects | Q42206242 | ||
| Absence of HTLV-1/2 infection among HCV-infected patients with no HIV-1/2 infection in Spain | Q43047039 | ||
| Prevalence of human T-lymphotropic virus type 1 and 2 infection in Sweden | Q43422896 | ||
| Human T-cell lymphocytotrophic virus prevalence in German blood donors and "at-risk" groups | Q44049446 | ||
| HTLV-1-associated myelopathy/tropical spastic paraparesis | Q45096240 | ||
| Multiple retroviral infection by HTLV type 1, 2, 3 and simian foamy virus in a family of Pygmies from Cameroon | Q45371164 | ||
| Geographic distribution of human T-lymphotropic virus types 1 and 2 among mothers of newborns tested during neonatal screening, Minas Gerais, Brazil | Q45374762 | ||
| Blood safety strategies for human T-cell lymphotropic virus in Europe | Q45388024 | ||
| Evaluation of the human immunodeficiency virus type 1 and 2 antibodies detection in dried whole blood spots (DBS) samples | Q45393948 | ||
| Coinfection with HIV-1 and human T-Cell lymphotropic virus type II in intravenous drug users is associated with delayed progression to AIDS. | Q45421768 | ||
| High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland | Q45749111 | ||
| Dried sera for confirming blood-borne virus infections (HCV, HTLV-I, HIV & HBsAg). | Q45765555 | ||
| Prevalence of human T-cell lymphotropic virus infections in Germany. | Q45783112 | ||
| Detection of antibodies to human immunodeficiency virus (HIV) in eluates from whole blood impregnated filter paper discs | Q45831387 | ||
| HTLV-2b among HIV type 1-coinfected injecting drug users in Spain | Q46877167 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | seroprevalence | Q3511357 |
| P304 | page(s) | e0183496 | |
| P577 | publication date | 2017-08-22 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | No significant HTLV seroprevalence in German people who inject drugs | |
| P478 | volume | 12 |
| Q92343287 | Molecular detection of human T-lymphotropic virus type 1 infection among oncology patients in Germany: A retrospective view | cites work | P2860 |
Search more.